Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
113.60
-1.80 (-1.56%)
At close: Feb 11, 2026

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,2722,436----
Enterprise Value
2,3152,496----
Last Close Price
113.60119.61----
PE Ratio
23.3530.51----
Forward PE
19.7924.86----
PS Ratio
4.956.18----
PB Ratio
6.126.62----
P/TBV Ratio
7.297.67----
P/FCF Ratio
27.03100.97----
P/OCF Ratio
22.5469.02----
EV/Sales Ratio
5.046.33----
EV/EBITDA Ratio
19.4625.19----
EV/EBIT Ratio
21.6127.95----
EV/FCF Ratio
27.54103.45----
Debt / Equity Ratio
0.170.180.200.300.330.25
Debt / EBITDA Ratio
0.520.660.731.111.050.72
Debt / FCF Ratio
0.742.710.861.443.445.49
Asset Turnover
0.870.800.760.700.73-
Inventory Turnover
1.561.681.441.371.45-
Quick Ratio
1.741.851.491.361.591.52
Current Ratio
2.652.652.362.222.302.66
Return on Equity (ROE)
27.90%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
12.64%11.39%10.83%10.10%12.09%-
Return on Invested Capital (ROIC)
23.93%21.61%20.57%18.76%22.59%25.18%
Return on Capital Employed (ROCE)
25.40%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
4.28%3.28%----
FCF Yield
3.70%0.99%----
Dividend Yield
2.17%1.67%----
Payout Ratio
48.29%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
2.16%1.67%----
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.